The absorption of dermally applied 1`Chexachlorobenzene ("4C-HCB; ranging from 2-5 to 2-6 mg/4 cm2) was investigated in the rat.
The absorbed portion increased from 1% at six hours to 9-7% at 72 hours after dosing and blood concentrations of '4C increased linearly with time. The rate of absorption was 3-51 (SD 0-81) pglh/4 cm2 and the absorption constant 1-40 (SD 0-33) x 10'Ih. Washing with soap at six hours after dosing removed 34% of the dose and decreased absorption by 50% in the next 66 hours. Finally, the compartment model, which incorporated the absorption constant, simulated the time profile of HCB kinetics in blood, and that ofcumulative excretion in rats. The model with the absorption constant for the rat was then scaled up for a 70 kg worker, whose exposure was assumed to be exclusively dermal. A rough dermal contamination, which corresponds to the tentative HCB critical blood concentration of 200 ppb, was calculated for different simulated biological half lives. It was 18-2 mg for 100, 5 02 mg for 365, and 2-56 mg for 730 day half lives. The study indicates that dermal contamination can be a source of HCB body burden, and that personal hygiene, such as taking a shower and hand washing is likely to have a profound influence on the body burden of HCB.
Hexachlorobenzene (HCB), a fungicidal compound and a byproduct in the manufacture of chlorinated solvents, is a suspected carcinogen in man.' Thus exposure to this compound, known to occur among workers manufacturing chlorinated solvents presents a health hazard.23 Intensive investigation into HCB exposure showed that concentrations of HCB in blood were strongly associated with years of employment, but poorly correlated with either traditional industrial hygiene measures or job category based exposure estimates.2 Thus blood concentrations of HCB in employees appeared to be influenced more by plant housekeeping procedures, personal hygiene, or habits, than by atmospheric concentrations. Consequently, it has been assumed that body burdens of recovered from urine, faeces, liver and carcass, from the skin not directly contaminated, and the subcutaneous tissue increased with the duration of exposure after dosing, from 1 05% at six hours to 9 71% at 72 hours (table 2). As expected, the cumulative absorbed portions were decreased by almost 50% by washing.
The absorption rate across the skin was calculated by assuming that the absorption process could be described by a one compartment linear pharmacokinetic model (see appendix) in which the cumulative absorption is a linear function of time. This assumption was justified by the linear increases found in the cumulative absorbed amounts of '4C-HCB. The absorption constant was calculated to be 1 40 (SD 0-33) x 10-'/h (table 3) .
RELATION BETWEEN BLOOD CONCENTRATION AND DERMAL DOSE
It is of practical importance to determine whether dermal exposure to HCB can account for the blood HCB concentrations found in plant workers. To answer this question, a pharmacokinetic model was developed for dermal exposure. Although it is well known that physiologically based pharmacokinetic models are superior to compartment models,6 the limited information on physiological parameters did not allow us to take this approach. Consequently, quantitative analyses were performed using a three linear compartment model (fig 1).3 The model was applied to the present data to simulate HCB kinetics with or without washing (fig 2) . In this model, parameters were the same as those in monkeys, except that the elimination constant (KT) was eight times larger in rats than in monkeys (table 4). The model was then scaled up for a 70 kg worker, assuming the direct incorporation of dermally applied HCB into compartment 1 (fig 1) . It was also tTotal amounts recovered from urine, faeces, liver, carcass, and the remaining skin (except the dose area) and subcutaneous tissues. tMean relative absorption was calculated by dividing the cumulative absorbed amount by the total dose. §The dose initially applied was 2641 (108 9) ug of which 904 5 (34-0) pg was washed at six hours. tThe total of K12 + KT was changed depending on the biological half lives (see, Equation B-Il in appendix). For a biological half life of 100 days, K12 + KT was 0-00749 (-/h), for that of 365 days, it was 0 0002049 (-/h), and for that of 730 days, it was 0 00010025 (-/h). For simulation, the half of the total values were assigned to K12 and KT by assuming K12 = KT. This assignment has little influence on the relation between blood concentrations and dermal doses under a steady state when K21 is much smaller than either K12 or KT as discussed in the appendix.
assumed that exposure was exclusively by the dermal route, and that the absorption constant in workers was the same as in rats.
The critical dermal doses resulting in 200 ppb of HCB in blood, regarded as the upper safe limit,2 were estimated for three different biological half lives by the Equation B-14 (appendix). Using these initial values, computer simulations for half lives of 100 days, 365 days, and 730 days were performed to calculate the doses that gave HCB concentrations in blood close to 200 ppb (table 5) .
Discussion
In the present study, absorption of HCB was found to proceed as a linear function of time after dermal application. The time cumulative absorbed amount profile enabled the calculation of the absorption rate constant for rats. The pharmacokinetic model, incorporating dermal absorption, gave estimates of dermal doses resulting in 200 ppb HCB in blood after long term (year order) exposures. Such a blood concentration can be the result of dermal exposure ranging from 18 2 mg to 2 56 mg. Such a contamination is small enough to go unnoticed. The calculated doses have inevitable errors as they were given;by a simple three compartment model in which parameters obtained from rats and monkeys were used. The model, therefore, ignored species differences and differences in skin permeability at various anatomical sites, both of which are known to be important factors.78 Despite these simplifications and uncertainties inherent in the model, the present study demonstrates the significance of dermal absorption.
It has been reported that blood concentrations of HCB in employees correlated poorly with either traditional hygiene measures or job category based exposure estimates.2 Trace amounts of HCB may be easily absorbed from skin if workers do not wash contaminated skin areas intentionally. Therefore, persistent skin contamination may be more important than airborne HCB. In such cases, the dermal Table 5 Calculated dermal 
